{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:10:30Z","timestamp":1783933830060,"version":"3.55.0"},"reference-count":47,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Committee of Science of the Ministry of Science &High Education of the Republic of Kazakhstan","award":["IRN BR27101179"],"award-info":[{"award-number":["IRN BR27101179"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The continuous search for new chemical structures more active and less toxic than those currently in practice is justified on the basis of the use of proven pharmacophoric building blocks (benzimidazole heterocycle, sulfonyl group and amidoxime framework in our case). The aim of the work was to synthesize new O-alkylsulfonyl-\u03b2-(benzimidazol-1-yl)propioamidoximes and to test them for in vitro biological activities to identify potentially effective agents. Novel O-alkylsulfonylamidoximes were synthesized in hydrochloride and base forms by the reaction of \u03b2-(benzimidazol-1-yl)propioamidoxime with alkylsulfonyl chlorides AlkSO2Cl (Alk = CH3, n-C3H7, i-C3H7, n-C4H9) in a mixture of water:acetone in hydrochloride and base forms. Hydrochlorides and bases of the O-alkylsulfonyl-\u03b2-(benzimidazol-1-yl)propioamidoximes were obtained in moderate to high yields. The structures of the synthesized compounds were established by physicochemical and spectral (elemental analysis, FT-IR, NMR and X-ray diffraction) methods. The obtained derivatives were tested for antimicrobial, antifungal and antidiabetic activity. Biological screening found effective samples of amidoximes with antimicrobial and antifungal activities that were near or exceeded the activity of the reference drugs gentamicin and nystatin; in addition, two samples with antidiabetic activity higher than acarbose were found. The results of the present study open new possibilities for the novel \u03b2-aminopropioamidoxime class as active antimicrobial and antifungal agents, as well as antidiabetic ones.<\/jats:p>","DOI":"10.3390\/ijms27146224","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:53:58Z","timestamp":1783932838000},"page":"6224","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural Modifications of Hybrid O-Alkylsulfonyl-\u03b2-(Benzimidazol-1-yl)propioamidoximes as a Pathway to the Antimicrobial, Antifungal and Antidiabetic Drugs"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1900-1228","authenticated-orcid":false,"given":"Lyudmila","family":"Kayukova","sequence":"first","affiliation":[{"name":"Laboratory of Chemistry of Synthetic and Natural Drug Substances, JSC A.B. Bekturov Institute of Chemical Sciences, 106 Shokan Ualikhanov Str., Almaty 050010, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-303X","authenticated-orcid":false,"given":"Anna","family":"Vologzhanina","sequence":"additional","affiliation":[{"name":"X-Ray Diffraction Laboratory, A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5165-6657","authenticated-orcid":false,"given":"Ekaterina","family":"Dubasova","sequence":"additional","affiliation":[{"name":"Laboratory of Quantum Chemistry, N.S. Kurnakov Institute of Inorganic and General Chemistry, Russian Academy of Sciences, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-4961","authenticated-orcid":false,"given":"Roza","family":"Seidakhmetova","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Evidence-Based Medicine, Karaganda Medical University, Karaganda 100012, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5482-7621","authenticated-orcid":false,"given":"Azamat","family":"Yerlanuly","sequence":"additional","affiliation":[{"name":"Laboratory of Chemistry of Synthetic and Natural Drug Substances, JSC A.B. Bekturov Institute of Chemical Sciences, 106 Shokan Ualikhanov Str., Almaty 050010, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruzhan","family":"Sartoyeva","sequence":"additional","affiliation":[{"name":"Laboratory of Chemistry of Synthetic and Natural Drug Substances, JSC A.B. Bekturov Institute of Chemical Sciences, 106 Shokan Ualikhanov Str., Almaty 050010, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigul","family":"Malmakova","sequence":"additional","affiliation":[{"name":"Laboratory of Chemistry of Synthetic and Natural Drug Substances, JSC A.B. Bekturov Institute of Chemical Sciences, 106 Shokan Ualikhanov Str., Almaty 050010, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"ref_1","first-page":"1683","article-title":"Structural Hybridizationas An Efficient Method for Novel Drug Candidates","volume":"3","author":"Mishra","year":"2025","journal-title":"Int. J. Pharm. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"Krueger","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2174\/156802661709170213205211","article-title":"Editorial (Thematic Issue: Hybrid Compounds as Multitarget Agents in Medicinal Chemistry\u2014PartII)","volume":"17","author":"Scotti","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s43440-023-00501-4","article-title":"Polypharmacology: Promises and newdrugs in 2022","volume":"75","author":"Ryszkiewicz","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"152403","DOI":"10.1016\/j.tetlet.2020.152403","article-title":"Application of amidoximes for the heterocycles synthesis","volume":"61","author":"Baykov","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.24959\/ophcj.16.878","article-title":"Amidoximes and their masked derivatives as prodrugs of amidines\u2014Argininemimetics","volume":"14","author":"Ovdiichuk","year":"2016","journal-title":"J. Org. Pharm. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/cmdc.202000349","article-title":"A Novel Prodrug of an NOS Inhibitor with Improved Pharmacokinetic Potential","volume":"15","author":"Maccallini","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Clement, B., and Struwe, M.A. (2023). The History of mARC. Molecules, 28.","DOI":"10.3390\/molecules28124713"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/bs.mie.2021.11.008","article-title":"Assessing and utilizing esterase specificity in antimicrobial prodrug development","volume":"664","author":"Hetrick","year":"2022","journal-title":"Methods Enzymol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1039\/D2CS00957A","article-title":"Prodrugs as empowerring tools in drug discovery and development: Recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates","volume":"53","author":"Subbaiah","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s43094-024-00673-7","article-title":"L-arginine: Its role in human physiology, in some diseases and mainly in viral multiplication as a narrative literature review","volume":"10","author":"Pedrazini","year":"2024","journal-title":"Future J. Pharm. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1017\/S0031182013000292","article-title":"Novel amidines and analogues as promising agents against intracellular parasites: A systematic review","volume":"140","author":"Soeiro","year":"2013","journal-title":"Parasitology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12967-025-06293-w","article-title":"Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumorproperties","volume":"23","author":"Farzin","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e32010","DOI":"10.1016\/j.heliyon.2024.e32010","article-title":"Amidine containing compounds: Antimicrobial activity and its potential in combating antimicrobial resistance","volume":"10","author":"Abidin","year":"2024","journal-title":"Heliyon"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1002\/jps.24508","article-title":"Zanamivir Amidoxime- and N-Hydroxyguanidine-BasedProdrug Approaches toT ackle Poor Oral Bioavailability","volume":"104","author":"Schade","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/14756361003733647","article-title":"Analysis of highly potent amidine containing inhibitors of serineproteases and their N-hydroxylated prodrugs(amidoximes)","volume":"26","author":"Kotthaus","year":"2011","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.bmcl.2019.06.045","article-title":"Evaluation of amidoxime derivatives as prodrug candidates of potent bis-cationic antimalarials","volume":"29","author":"Berger","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1745-6150-6-63","article-title":"Purine biosynthesis in archaea: Variations on a theme","volume":"6","author":"Brown","year":"2011","journal-title":"Biol. Direct."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/0115734064253813231025093707","article-title":"A Critical Review on the rapeutic Potential of Benzimidazole Derivatives: A Privileged Scaffold","volume":"20","author":"Natarajan","year":"2024","journal-title":"Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.32441\/kjps.08.02.p11","article-title":"Benzimidazole and Its Derivatives: Exploring Their Crucial Role in Medicine and Agriculture: A Short Review","volume":"8","author":"Fawzi","year":"2024","journal-title":"Al-Kitab J. Pure Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and Medicinal Significance of Sulfur(SVI)- Containing Motifs for Drug Discovery: A Critical Review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Benedetto Tiz, D., Rosati, O., and Sancineto, L. (2025). Sulfur- and phosphorus- containing FDA approved drugs in the last five years (2020\u20132024): A journey among small molecules. Phosphorus Sulfur Silicon Relat. Elem., 1\u201339.","DOI":"10.1080\/10426507.2025.2496521"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.aac.2022.12.003","article-title":"Synthesis and perspective of organosulfur chemicals in agrochemicals","volume":"2","author":"Yu","year":"2023","journal-title":"Adv. Agrochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/17460441.2022.2044783","article-title":"The Importance of Sulfur-Containing Motifs in Drug Design and Discovery","volume":"17","author":"Mustafa","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867033457647","article-title":"Anticancer and Antiviral Sulfonamides","volume":"10","author":"Scozzafava","year":"2003","journal-title":"Cur. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.17816\/2313-8726-2021-8-4-207-212","article-title":"Possibility of use and effectiveness soforal1 hypoglyctic drugs ingestationaldiabetes mellitus: A literature review","volume":"8","author":"Russkova","year":"2021","journal-title":"VF Snegirev Arch. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14656566.2021.1999413","article-title":"The role of sulfonyl ureas in the treatment of type 2 diabetes","volume":"23","author":"Tomlinson","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_28","unstructured":"Tomlin, C.D.S. (2024). The Pesticide Manual (British Crop Protection Council, Farnham, BCPC Publications. [20th ed.]. Pesticide Manual Online."},{"key":"ref_29","unstructured":"(2026, July 07). Global Sulfonylurea Herbicide Market Overview\u2014Competitive Landscape, Trends&Forecast by Segment. Report ID956760. Available online: https:\/\/www.marketresearchintellect.com\/product\/sulfonylurea-herbicide-market\/."},{"key":"ref_30","unstructured":"(2026, July 07). Global Sulfonylurea Herbicide Market Size by Product (Chlorpropamide, Glyburide), by Application Method(Soil Application, Foliar Application), By Crop Type (Cereal Crops, Fruits and Vegetables), By Formulation (Granules, Liquid Concentrates), by Distribution Channel (Online, Offline), by Geographic Scope and Forecast. Report ID: 271650, Published: February 2025, Study Period: 2023\u20132033. Available online: https:\/\/www.verifiedmarketreports.com\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1074\/jbc.M211648200","article-title":"Molecular basis of sulfonyl urea herbicide inhibition of acetohydroxy acid synthase","volume":"278","author":"Pang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_32","first-page":"22","article-title":"Arylsulphonates of spiropyrazolines and O-tosilate-\u03b2-(benzimidazol-1-yl)propioamidoxime as the products of \u03b2-aminopropioamidoximes tosylation","volume":"2","author":"Kayukova","year":"2021","journal-title":"Chem. J. Kaz."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kayukova, L., Vologzhanina, A., Dorovatovskii, P., Baitursynova, G., Yergaliyeva, E., Kurmangaliyeva, A., Shulgau, Z., Adekenov, S., Shaimerdenova, Z., and Akatan, K. (2022). Reaction Products of \u03b2-Aminopropioamidoximes Nitrobenzenesulfochlorination: Linear and Rearranged to Spiropyrazolinium Salts with Antidiabetic Activity. Molecules, 27.","DOI":"10.3390\/molecules27072181"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3987\/COM-00-8900","article-title":"Suggestion of Unexpected Sulfur Dioxide Mechanism for Deoxygenations of Pyridine N-Oxides with Alkanesulfonyl Chlorides and Triethylamine","volume":"53","author":"Morimoto","year":"2000","journal-title":"Heterocycles"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1139\/v76-374","article-title":"Organic sulfur mechanisms. 19. Sulfene\u2013tertiary amine zwitterions and base size effects in sulfene condensations","volume":"54","author":"King","year":"1976","journal-title":"Can. J. Chem."},{"key":"ref_36","unstructured":"Kayukova, L.A., Uzakova, A.B., Erlanuly, A., Sartoeva, A.B., and Seidakhmetova, R.B. (2024, December 13). Compound O-iso-propylsulfonyl-\u03b2-(benzim idazol-1-yl)propioamidoxime, Possessing Antifungal Activity on the Yeast Fungus Candida albicans ATCC10231. KZ Patent for Utility Model 9924. Available online: www.qazpatent.kz."},{"key":"ref_37","unstructured":"Kayukova, L.A., Duysenali, A.M., Erlanuly, A., Shulgau, Z.T., and Sergazy, S.D. (2025, July 25). Use of the Compound O-methylsulfonyl -beta-(benzimidazol-1-yl)propioamidoxime Hydrochloride as an Antidiabetic Agent. KZ Patent for a Utility Model 10917. Available online: www.qazpatent.kz."},{"key":"ref_38","unstructured":"Kayukova, L.A., Erlanuly, A., Shulgau, Z.T., and Sergazy, S.D. (2025, May 02). O-Butylsulfonyl-beta-(benzimidazol-1-yl)propioamidoxime hydro Chloride with InVitro Antidiabetic Activity. KZ Patentfor Utility Model 10488. Available online: www.qazpatent.kz."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.5114\/aoms.2012.31621","article-title":"\u03b1-Glucosidase inhibitors and their use in clinicalpractice","volume":"8","author":"Derosa","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11101-021-09773-1","article-title":"Ar eview of alpha-glucosidase inhibitors from plants aspotential candidatesfor the treatment of type-2 diabetes","volume":"21","author":"Dirir","year":"2022","journal-title":"Phytochem. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dreier, J., and Ruggerone, P. (2015). Interaction of antibacterial compounds with RN Defflux pumps in Pseudomonas aeruginosa. Front. Mcrobiol., 6.","DOI":"10.3389\/fmicb.2015.00660"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gerni, S., \u00d6zt\u00fcrk, C., Bayrak, S., Demir, Y., Atmaca, U., Milenkovi\u0107, D., Dimi\u0107, D., and K\u00fcfrevio\u011flu, \u00d6.I. (2026). Unnatural amino acidcompounds as potent multi-target inhibitors of aldosereductase, \u03b1-glucosidase, and \u03b1-amylase: Integrated in vitro, SAR, and molecular dynamics insights. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol.","DOI":"10.1007\/s00210-026-05249-1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14756366.2020.1715386","article-title":"Design, synthesis and \u03b1-glucosidase inhibition study of novel embelin derivatives","volume":"35","author":"Chen","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT\u2014Integrated space-group and crystal structure determination","volume":"1","author":"Sheldrick","year":"2015","journal-title":"Found. Crystallogr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Cryst. Struct. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: A complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"Appl. Cryst."},{"key":"ref_47","unstructured":"Mironov, A.N. (2012). Guidelines for Conducting of Preclinical Studies of Medicinal Products, GrifK. (In Russian)."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6224\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:58:20Z","timestamp":1783933100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":47,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146224"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146224","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]}}}